Mechanisms of fatal opioid overdose

被引:447
|
作者
White, JM [1 ]
Irvine, RJ [1 ]
机构
[1] Univ Adelaide, Dept Clin & Expt Pharmacol, Adelaide, SA 5005, Australia
关键词
D O I
10.1046/j.1360-0443.1999.9479612.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
There has been increasing recognition of the problem of fatal opioid overdose. This review examines the pharmacological basis of respiratory depression following opioid administration. Respiration is controlled principally through medullary respiratory centres with peripheral input from chemoreceptors and other sources. Opioids produce inhibition at the chemoreceptors via mu opioid receptors and in the medulla via mu and delta receptors. While there are a number of neurotransmitters mediating the control of respiration, glutamate and GABA are the major excitatory and inhibitory neurotransmitters, respectively. This explains the potential for interaction of opioids with benzodiazepines and alcohol: bath benzodiazepines and alcohol facilitate the inhibitory effect of GABA at the GABA(A) receptor, while alcohol also decreases the excitatory effect of glutamate at NMDA receptors. Heroin and methadone are the major opioids implicated in fatal overdose. Heroin has three metabolites with opioid activity. Variation in the formation of these metabolites due to genetic factors and the use of other drugs could explain differential sensitivity to overdose. Metabolites of methadone contribute little to its action. However, variation in I ate of metabolism due to genetic factors and other drugs used can modify methadone concentration and hence overdose risk. The degree of tolerance also determines risk. Tolerance to respiratory depression is less than complete, and may be slower than tolerance to euphoric and other effects. One consequence of this may be a relatively high risk of overdose among experienced opioid users. While agonist administration modifies receptor function, changes (usually in the opposite direction) also result front use of antagonists. The potential for, supersensitivity to opioids following a period of administration of antagonists such as naltrexone warrants further investigation. While our understanding of the pharmacological basis of opioid-related respiratory depression has advanced, better understanding of the role of heroin metabolites, the metabolism of methadone, drug interactions and tolerance would all be of considerable value in knowing how best to respond to this problem.
引用
收藏
页码:961 / 972
页数:12
相关论文
共 50 条
  • [21] Homelessness and Veteran Status in Relation to Nonfatal and Fatal Opioid Overdose in Massachusetts
    Jasuja, Guneet K.
    Bettano, Amy
    Smelson, David
    Bernson, Dana
    Rose, Adam J.
    Byrne, Thomas
    Berlowitz, Dan R.
    McCullough, Megan B.
    Miller, Donald R.
    MEDICAL CARE, 2021, 59 (04) : S165 - S169
  • [22] Socioeconomic correlates of incident and fatal opioid overdose among Swedish people with opioid use disorder
    Dahlman, Disa
    Ohlsson, Henrik
    Edwards, Alexis C.
    Sundquist, Jan
    Hakansson, Anders
    Sundquist, Kristina
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2021, 16 (01)
  • [23] The Role of the Social Network in Fatal Opioid Overdose Prevention: The Former Opioid User's Perspective
    Wygonik, Quri
    Glassman, Tavis
    Tucker-Gail, Kasey
    JOURNAL OF DRUG ISSUES, 2021, 51 (03) : 576 - 589
  • [24] Socioeconomic correlates of incident and fatal opioid overdose among Swedish people with opioid use disorder
    Disa Dahlman
    Henrik Ohlsson
    Alexis C. Edwards
    Jan Sundquist
    Anders Håkansson
    Kristina Sundquist
    Substance Abuse Treatment, Prevention, and Policy, 16
  • [25] Impact of the naloxone standing order on trends in opioid fatal overdose: an ecological analysis
    Taylor, Michelle
    Pradhan, Apoorva
    Ogando, Yoscar M.
    Shaya, Fadia
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2022, 48 (03): : 338 - 346
  • [26] Hippocampal Volume Loss in Individuals with a History of Non-Fatal Opioid Overdose
    Todaro, Dustin
    Li, Xinyi
    Pereira-Rufino, Lais da Silva
    Manza, Peter
    Nasrallah, Ilya
    Das, Sandhitsu
    Childress, Anna Rose
    Kranzler, Henry
    Volkow, Nora
    Langleben, Daniel
    Shi, Zhenhao
    Wiers, Corinde
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 493 - 493
  • [27] Potential risk for fatal drug overdose perceived by people using opioid drugs
    Deering, Daryle E. A.
    Adamson, Simon J.
    Sellman, John D.
    Henderson, Charles
    Sheridan, Janie
    Pooley, Sheridan
    Robertson, Rhonda Marie
    Noller, Geoff
    Frampton, Christopher M. A.
    DRUG AND ALCOHOL REVIEW, 2018, 37 : S309 - S313
  • [28] The Effect of Naloxone Access Laws on Fatal Synthetic Opioid Overdose Fatality Rates
    Tabatabai, Mohammad
    Cooper, Robert L. L.
    Wilus, Derek M. M.
    Edgerton, Ryan D. D.
    Ramesh, Aramandla
    MacMaster, Samuel A. A.
    Patel, Parul N. N.
    Singh, Karan P. P.
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2023, 14
  • [29] Psychostimulant drug co-ingestion in non-fatal opioid overdose
    Shastry, Siri
    Shulman, Joshua
    Aldy, Kim
    Brent, Jeffrey
    Wax, Paul
    Manini, Alex F.
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2024, 10
  • [30] Hippocampal volume loss in individuals with a history of non-fatal opioid overdose
    Todaro, Dustin R.
    Li, Xinyi
    Pereira-Rufino, Lais S.
    Manza, Peter
    Nasrallah, Ilya M.
    Das, Sandhitsu
    Childress, Anna Rose
    Kranzler, Henry R.
    Volkow, Nora D.
    Langleben, Daniel D.
    Shi, Zhenhao
    Wiers, Corinde E.
    ADDICTION BIOLOGY, 2023, 28 (10)